FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1973865713> ?p ?o ?g. }

• W1973865713 endingPage "e101889" @default.
• W1973865713 startingPage "e101889" @default.
• W1973865713 abstract "In this study, our objective is to evaluate the potential of a novel Sorafenib derivative, named HLC-080, as a new anticancer agent for colon cancer. We firstly carried out MTT assay, colony formation assay, flow cytometry analysis and transwell invasion assay to determine effect of our compound HLC-080 on cell viability, anti-proliferation activity, cell cycle arrest and the intervention on cell invasion, respectively. On the other hand, in vivo antitumor activity of HLC-080 was also tested using H22 xenograft model and the angiogenesis effect of HLC-080 was measured by EA.hy926 tube formation assay. The expression levels of various proteins in HLC-080 treated with HT-29 cell lines were examined using Western blot and ELISA experiments. The results showed that HLC-080 could dramatically inhibit the growth and colony formation of various tumor cells, therefore exhibited remarkable antitumor activity. HLC-080 can induce cell cycle arrest at G1 phase in HT-29 cells and subsequently inhibit the invasive potential of colon cancer cells. HLC-080 also exhibits anti-angiogenesis effect in EA.hy926 model. Additionally, the in vivo study showed that HLC-080 was able to reduced the tumor weight with the rate of 35.81%. And at the concentration of 0.352±0.034 µM, HLC-080 is able to reduce half of the regular protein level of p-c-Raf (Ser259), consequently block Raf/MEK/ERK signaling in HT-29 cell lines. In conclusion, our study suggests that Sorafenib derivative HLC-080 has the potential to inhibit cell proliferation and angiogenesis, Since, HLC-080 is particularly active against human colon cancer cells, our study highlights that HLC-080 and its related analogues may serve as a new anti-cancer drug, particularly against colon cancer." @default.
• W1973865713 created "2016-06-24" @default.
• W1973865713 creator A5024827414 @default.
• W1973865713 creator A5033591339 @default.
• W1973865713 creator A5038805449 @default.
• W1973865713 creator A5039096170 @default.
• W1973865713 creator A5049594854 @default.
• W1973865713 creator A5068450687 @default.
• W1973865713 creator A5076020154 @default.
• W1973865713 date "2014-07-08" @default.
• W1973865713 modified "2023-10-16" @default.
• W1973865713 title "The Study of a Novel Sorafenib Derivative HLC-080 as an Antitumor Agent" @default.
• W1973865713 cites W104105986 @default.
• W1973865713 cites W1965082667 @default.
• W1973865713 cites W1981017654 @default.
• W1973865713 cites W1982079095 @default.
• W1973865713 cites W1983833034 @default.
• W1973865713 cites W1995938892 @default.
• W1973865713 cites W1997533142 @default.
• W1973865713 cites W2004970645 @default.
• W1973865713 cites W2007464029 @default.
• W1973865713 cites W2031856001 @default.
• W1973865713 cites W2032648482 @default.
• W1973865713 cites W2033288159 @default.
• W1973865713 cites W2043099487 @default.
• W1973865713 cites W2047565976 @default.
• W1973865713 cites W2051213986 @default.
• W1973865713 cites W2052550764 @default.
• W1973865713 cites W2054095401 @default.
• W1973865713 cites W2061345986 @default.
• W1973865713 cites W2066071585 @default.
• W1973865713 cites W2066501741 @default.
• W1973865713 cites W2070017800 @default.
• W1973865713 cites W2070396671 @default.
• W1973865713 cites W2082777374 @default.
• W1973865713 cites W2099259685 @default.
• W1973865713 cites W2116177733 @default.
• W1973865713 cites W2119402609 @default.
• W1973865713 cites W2131217588 @default.
• W1973865713 cites W2139213909 @default.
• W1973865713 cites W2140765540 @default.
• W1973865713 cites W2142476858 @default.
• W1973865713 cites W2149026055 @default.
• W1973865713 cites W2161377790 @default.
• W1973865713 cites W2161817637 @default.
• W1973865713 cites W2166271687 @default.
• W1973865713 cites W35193510 @default.
• W1973865713 doi "https://doi.org/10.1371/journal.pone.0101889" @default.
• W1973865713 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4086976" @default.
• W1973865713 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25004130" @default.
• W1973865713 hasPublicationYear "2014" @default.
• W1973865713 type Work @default.
• W1973865713 sameAs 1973865713 @default.
• W1973865713 citedByCount "10" @default.
• W1973865713 countsByYear W19738657132015 @default.
• W1973865713 countsByYear W19738657132017 @default.
• W1973865713 countsByYear W19738657132018 @default.
• W1973865713 countsByYear W19738657132020 @default.
• W1973865713 countsByYear W19738657132021 @default.
• W1973865713 countsByYear W19738657132022 @default.
• W1973865713 countsByYear W19738657132023 @default.
• W1973865713 crossrefType "journal-article" @default.
• W1973865713 hasAuthorship W1973865713A5024827414 @default.
• W1973865713 hasAuthorship W1973865713A5033591339 @default.
• W1973865713 hasAuthorship W1973865713A5038805449 @default.
• W1973865713 hasAuthorship W1973865713A5039096170 @default.
• W1973865713 hasAuthorship W1973865713A5049594854 @default.
• W1973865713 hasAuthorship W1973865713A5068450687 @default.
• W1973865713 hasAuthorship W1973865713A5076020154 @default.
• W1973865713 hasBestOaLocation W19738657131 @default.
• W1973865713 hasConcept C104317684 @default.
• W1973865713 hasConcept C1491633281 @default.
• W1973865713 hasConcept C150903083 @default.
• W1973865713 hasConcept C153911025 @default.
• W1973865713 hasConcept C185592680 @default.
• W1973865713 hasConcept C207001950 @default.
• W1973865713 hasConcept C2776415932 @default.
• W1973865713 hasConcept C2778019345 @default.
• W1973865713 hasConcept C2778695046 @default.
• W1973865713 hasConcept C2780394083 @default.
• W1973865713 hasConcept C2780783641 @default.
• W1973865713 hasConcept C29537977 @default.
• W1973865713 hasConcept C502942594 @default.
• W1973865713 hasConcept C53227056 @default.
• W1973865713 hasConcept C54355233 @default.
• W1973865713 hasConcept C553184892 @default.
• W1973865713 hasConcept C55493867 @default.
• W1973865713 hasConcept C57074206 @default.
• W1973865713 hasConcept C62112901 @default.
• W1973865713 hasConcept C62478195 @default.
• W1973865713 hasConcept C81885089 @default.
• W1973865713 hasConcept C86803240 @default.
• W1973865713 hasConceptScore W1973865713C104317684 @default.
• W1973865713 hasConceptScore W1973865713C1491633281 @default.
• W1973865713 hasConceptScore W1973865713C150903083 @default.
• W1973865713 hasConceptScore W1973865713C153911025 @default.
• W1973865713 hasConceptScore W1973865713C185592680 @default.
• W1973865713 hasConceptScore W1973865713C207001950 @default.

• next